Advertisement
Screener

REPLIGEN CORP (RGEN) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

REPLIGEN CORP Capital Expenditures

REPLIGEN CORP (RGEN) reported Capital Expenditures of $10.04 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-07-29

  • REPLIGEN CORP payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $5.33M, a 24.88% decline year-over-year.
  • REPLIGEN CORP payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $4.71M, a 32.19% increase year-over-year.
  • REPLIGEN CORP payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $8.15M, a 47.17% increase year-over-year.
  • REPLIGEN CORP payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $4.70M, a 32.67% decline year-over-year.
  • REPLIGEN CORP payments to acquire property, plant, and equipment for fiscal 2025 was $23.52M, a 8.40% decline from fiscal 2024.
  • REPLIGEN CORP payments to acquire property, plant, and equipment for fiscal 2024 was $25.68M, a 29.11% decline from fiscal 2023.
  • REPLIGEN CORP payments to acquire property, plant, and equipment for fiscal 2023 was $36.22M, a 57.30% decline from fiscal 2022.
  • REPLIGEN CORP payments to acquire property, plant, and equipment for fiscal 2022 was $84.83M, a 26.45% increase from fiscal 2021.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 3 month as first filedPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 6 month as first filedPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 9 month as first filedPayments to Acquire Property, Plant, and Equipment 12 monthPayments to Acquire Property, Plant, and Equipment 12 month as first filed
2026-06-30$5.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
$10.04M
10-Q · filed 2026-07-29
$18.20M
derived: sum of 3 quarters · filed 2026-07-29
$22.90M
derived: sum of 4 quarters · filed 2026-07-29
2026-03-31$4.71M
10-Q · filed 2026-05-06
$12.86M
derived: sum of 2 quarters · filed 2026-05-06
$17.57M
derived: sum of 3 quarters · filed 2026-05-06
$24.67M
derived: sum of 4 quarters · filed 2026-07-29
2025-12-31$8.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$12.86M
derived: sum of 2 quarters · filed 2026-02-26
$19.96M
derived: sum of 3 quarters · filed 2026-07-29
$23.52M
10-K · filed 2026-02-26
2025-09-30$4.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$11.80M
derived: sum of 2 quarters · filed 2026-07-29
$15.37M
10-Q · filed 2025-11-04
$20.91M
derived: sum of 4 quarters · filed 2026-07-29
2025-06-30$7.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
$10.66M
10-Q · filed 2026-07-29
$16.20M
derived: sum of 3 quarters · filed 2026-07-29
$23.19M
derived: sum of 4 quarters · filed 2026-07-29
2025-03-31$3.56M
10-Q · filed 2026-05-06
$9.10M
derived: sum of 2 quarters · filed 2026-05-06
$16.09M
derived: sum of 3 quarters · filed 2026-05-06
$20.89M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$5.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$12.52M
derived: sum of 2 quarters · filed 2026-02-26
$17.33M
derived: sum of 3 quarters · filed 2026-02-26
$25.68M
10-K · filed 2026-02-26
2024-09-30$6.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$11.79M
derived: sum of 2 quarters · filed 2025-11-04
$20.14M
10-Q · filed 2025-11-04
$31.22M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$4.81M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$13.15M
10-Q · filed 2025-08-07
$24.24M
derived: sum of 3 quarters · filed 2026-02-26
$32.63M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$8.35M
10-Q · filed 2025-04-29
$19.43M
derived: sum of 2 quarters · filed 2026-02-26
$27.82M
derived: sum of 3 quarters · filed 2026-02-26
$36.06M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$11.09M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-26
$19.47M
derived: sum of 2 quarters · filed 2026-02-26
$27.71M
derived: sum of 3 quarters · filed 2026-02-26
$36.22M
10-K · filed 2026-02-26
2023-09-30$8.39M
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18
$16.63M
derived: sum of 2 quarters · filed 2024-11-18
$25.14M
10-Q/A · filed 2024-11-18
$45.58M
derived: sum of 4 quarters · filed 2025-03-14
2023-06-30$8.24M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18
$16.75M
10-Q/A · filed 2024-11-18
$37.19M
derived: sum of 3 quarters · filed 2025-03-14
$49.01M
derived: sum of 4 quarters · filed 2025-03-14
2023-03-31$8.51M
10-Q/A · filed 2024-11-18
$28.95M
derived: sum of 2 quarters · filed 2025-03-14
$40.77M
derived: sum of 3 quarters · filed 2025-03-14
$66.14M
derived: sum of 4 quarters · filed 2025-03-14
2022-12-31$20.44M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-03-14
$32.26M
derived: sum of 2 quarters · filed 2025-03-14
$57.63M
derived: sum of 3 quarters · filed 2025-03-14
$84.83M
10-K · filed 2025-03-14
2022-09-30$11.81M
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18
$37.19M
derived: sum of 2 quarters · filed 2024-11-18
$64.39M
10-Q/A · filed 2024-11-18
$96.51M
derived: sum of 4 quarters · filed 2024-11-18
2022-06-30$25.37M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18
$52.58M
10-Q/A · filed 2024-11-18
$84.70M
derived: sum of 3 quarters · filed 2024-11-18
$95.59M
derived: sum of 4 quarters · filed 2024-11-18
2022-03-31$27.20M
10-Q/A · filed 2024-11-18
$59.32M
derived: sum of 2 quarters · filed 2024-11-18
$70.22M
derived: sum of 3 quarters · filed 2024-11-18
$86.71M
derived: sum of 4 quarters · filed 2024-11-18
2021-12-31$32.12M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18
$43.01M
derived: sum of 2 quarters · filed 2024-11-18
$59.51M
derived: sum of 3 quarters · filed 2024-11-18
$67.09M
10-K/A · filed 2024-11-18
2021-09-30$10.89M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01
$27.39M
derived: sum of 2 quarters · filed 2022-11-01
$34.97M
10-Q · filed 2022-11-01
$46.36M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30$16.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
$24.08M
10-Q · filed 2022-08-02
$35.47M
derived: sum of 3 quarters · filed 2023-02-22
$39.24M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31$7.58M
10-Q · filed 2022-04-27
$18.97M
derived: sum of 2 quarters · filed 2023-02-22
$22.75M
derived: sum of 3 quarters · filed 2023-02-22
$25.91M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31$11.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$15.16M
derived: sum of 2 quarters · filed 2023-02-22
$18.33M
derived: sum of 3 quarters · filed 2023-02-22
$22.45M
10-K · filed 2023-02-22
2020-09-30$3.78M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28
$6.94M
derived: sum of 2 quarters · filed 2021-10-28
$11.07M
10-Q · filed 2021-10-28
$18.16M
derived: sum of 4 quarters · filed 2022-02-17
2020-06-30$3.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27
$7.29M
10-Q · filed 2021-07-27
$14.38M
derived: sum of 3 quarters · filed 2022-02-17
$19.95M
derived: sum of 4 quarters · filed 2022-02-17
2020-03-31$4.13M
10-Q · filed 2021-05-04
$11.22M
derived: sum of 2 quarters · filed 2022-02-17
$16.78M
derived: sum of 3 quarters · filed 2022-02-17
$20.54M
derived: sum of 4 quarters · filed 2022-02-17
2019-12-31$7.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17
$12.66M
derived: sum of 2 quarters · filed 2022-02-17
$16.42M
derived: sum of 3 quarters · filed 2022-02-17
$18.50M
10-K · filed 2022-02-17
2019-09-30$5.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$9.32M
derived: sum of 2 quarters · filed 2020-11-05
$11.41M
10-Q · filed 2020-11-05
$14.68M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$3.76M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30
$5.85M
10-Q · filed 2020-07-30
$9.11M
derived: sum of 3 quarters · filed 2021-02-24
$12.07M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$2.09M
10-Q · filed 2020-05-06
$5.36M
derived: sum of 2 quarters · filed 2021-02-24
$8.31M
derived: sum of 3 quarters · filed 2021-02-24
$11.16M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$3.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$6.22M
derived: sum of 2 quarters · filed 2021-02-24
$9.07M
derived: sum of 3 quarters · filed 2021-02-24
$10.63M
10-K · filed 2021-02-24
2018-09-30$2.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
$5.80M
derived: sum of 2 quarters · filed 2019-10-31
$7.37M
10-Q · filed 2019-10-31
$8.58M
10-Q · filed 2018-11-01
$9.14M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30$2.85M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
$4.41M
10-Q · filed 2019-08-01
$6.18M
derived: sum of 3 quarters · filed 2020-02-26
$7.19M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31$1.56M
10-Q · filed 2019-05-09
$3.33M
derived: sum of 2 quarters · filed 2020-02-26
$4.34M
derived: sum of 3 quarters · filed 2020-02-26
$5.72M
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31$1.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
$2.78M
derived: sum of 2 quarters · filed 2020-02-26
$4.16M
derived: sum of 3 quarters · filed 2020-02-26
$5.45M
10-K · filed 2020-02-26
2017-09-30$1.01M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
$2.39M
derived: sum of 2 quarters · filed 2018-11-01
$3.69M
10-Q · filed 2018-11-01
$4.55M
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30$1.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$2.68M
10-Q · filed 2018-08-02
$3.54M
derived: sum of 3 quarters · filed 2019-03-01
$5.59M
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31$1.29M
10-Q · filed 2018-05-08
$2.16M
derived: sum of 2 quarters · filed 2019-03-01
$4.21M
derived: sum of 3 quarters · filed 2019-03-01
$5.19M
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31$863.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
$2.92M
derived: sum of 2 quarters · filed 2019-03-01
$3.89M
derived: sum of 3 quarters · filed 2019-03-01
$4.33M
10-K · filed 2019-03-01
2016-09-30$2.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$3.03M
derived: sum of 2 quarters · filed 2017-11-09
$3.46M
10-Q · filed 2017-11-09
$4.04M
derived: sum of 4 quarters · filed 2018-02-22
2016-06-30$975.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
$1.41M
10-Q · filed 2017-08-03
$1.98M
derived: sum of 3 quarters · filed 2018-02-22
$2.30M
derived: sum of 4 quarters · filed 2018-02-22
2016-03-31$431.00K
10-Q · filed 2017-05-04
$1.00M
derived: sum of 2 quarters · filed 2018-02-22
$1.32M
derived: sum of 3 quarters · filed 2018-02-22
$1.79M
derived: sum of 4 quarters · filed 2018-02-22
2015-12-31$573.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
$891.00K
derived: sum of 2 quarters · filed 2018-02-22
$1.36M
derived: sum of 3 quarters · filed 2018-02-22
$2.63M
10-K · filed 2018-02-22
2015-09-30$318.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$783.00K
derived: sum of 2 quarters · filed 2016-11-03
$2.06M
10-Q · filed 2016-11-03
$4.69M
derived: sum of 4 quarters · filed 2017-02-23
2015-06-30$465.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$1.74M
10-Q · filed 2016-08-04
$1.74M
10-Q · filed 2015-08-06
$4.38M
derived: sum of 3 quarters · filed 2017-02-23
$6.11M
derived: sum of 4 quarters · filed 2017-02-23
2015-03-31$1.27M
10-Q · filed 2016-05-05
$1.27M
10-Q · filed 2015-05-08
$3.91M
derived: sum of 2 quarters · filed 2017-02-23
$5.65M
derived: sum of 3 quarters · filed 2017-02-23
$6.28M
derived: sum of 4 quarters · filed 2017-02-23
2014-12-31$2.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
$4.38M
derived: sum of 2 quarters · filed 2017-02-23
$5.01M
derived: sum of 3 quarters · filed 2017-02-23
$5.60M
10-K · filed 2017-02-23
$5.60M
10-K · filed 2015-03-17
2014-09-30$1.74M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$2.37M
derived: sum of 2 quarters · filed 2015-11-05
$2.96M
10-Q · filed 2015-11-05
$2.96M
10-Q · filed 2014-11-07
$3.82M
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30$627.30K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$1.22M
10-Q · filed 2015-08-06
$2.08M
derived: sum of 3 quarters · filed 2016-02-25
$4.75M
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31$596.79K
10-Q · filed 2015-05-08
$1.46M
derived: sum of 2 quarters · filed 2016-02-25
$4.13M
derived: sum of 3 quarters · filed 2016-02-25
$4.91M
derived: sum of 4 quarters · filed 2016-02-25
2013-12-31$860.15K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25
$3.53M
derived: sum of 2 quarters · filed 2016-02-25
$4.31M
derived: sum of 3 quarters · filed 2016-02-25
$4.63M
10-K · filed 2016-02-25
$4.63M
10-K · filed 2014-03-14
2013-09-30$2.67M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
$3.45M
derived: sum of 2 quarters · filed 2014-11-07
$3.77M
10-Q · filed 2014-11-07
$4.21M
derived: sum of 4 quarters · filed 2015-03-17
2013-06-30$783.12K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
$1.11M
10-Q · filed 2014-08-11
$1.54M
derived: sum of 3 quarters · filed 2015-03-17
$1.86M
derived: sum of 4 quarters · filed 2015-03-17
2013-03-31$322.10K
10-Q · filed 2014-05-09
$760.68K
derived: sum of 2 quarters · filed 2015-03-17
$1.07M
derived: sum of 3 quarters · filed 2015-03-17
$1.43M
derived: sum of 4 quarters · filed 2015-03-17
2012-12-31$438.59K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17
$750.13K
derived: sum of 2 quarters · filed 2015-03-17
$1.11M
derived: sum of 3 quarters · filed 2015-03-17
$1.26M
10-K · filed 2015-03-17
2012-09-30$311.55K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
$668.32K
derived: sum of 2 quarters · filed 2013-11-08
$825.06K
10-Q · filed 2013-11-08
$1.06M
derived: sum of 4 quarters · filed 2014-03-14
2012-06-30$356.77K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07
$513.51K
10-Q · filed 2013-08-07
$750.34K
derived: sum of 3 quarters · filed 2014-03-14
$920.97K
derived: sum of 4 quarters · filed 2014-03-14
2012-03-31$156.74K
10-Q · filed 2013-05-07
$393.56K
derived: sum of 2 quarters · filed 2014-03-14
$564.20K
derived: sum of 3 quarters · filed 2014-03-14
$732.20K
derived: sum of 4 quarters · filed 2014-03-14
2011-12-31$236.82K
derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-14
$407.45K
derived: sum of 2 quarters · filed 2014-03-14
$575.46K
10-K · filed 2014-03-14
$782.14K
derived: sum of 4 quarters · filed 2014-03-14
2011-09-30$170.63K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-09
$338.63K
10-Q · filed 2011-11-09
$545.32K
10-Q · filed 2012-11-08
$708.55K
derived: sum of 4 quarters · filed 2014-03-14
2011-06-30$168.00K
10-Q · filed 2011-08-05
$374.69K
10-Q · filed 2012-08-09
$537.92K
derived: sum of 3 quarters · filed 2014-03-14
$628.71K
derived: sum of 4 quarters · filed 2014-03-14
2011-03-31$206.68K
10-Q · filed 2012-05-10
$369.92K
derived: sum of 2 quarters · filed 2014-03-14
$460.71K
derived: sum of 3 quarters · filed 2014-03-14
$524.67K
10-K · filed 2013-03-15
2010-12-31$163.23K
derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-14
$254.03K
derived: sum of 2 quarters · filed 2014-03-14
$317.98K
10-K · filed 2014-03-14
2010-09-30$90.79K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-09
$154.75K
10-Q · filed 2011-11-09
2010-06-30$63.95K
10-Q · filed 2011-08-05
2010-03-31$597.35K
10-K · filed 2012-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Immunovant, Inc. (IMVT)United States$7.028B-14.78